What patient and disease characteristics do you consider when choosing a systemic therapy for patients with metastatic SCC?
Featuring Laura Ferris, MD, PhD |
Professor and Chair
UNC Department of Dermatology
Chapel Hill, North Carolina
Related CME
Related Media
Powered by Polaris TM